全文获取类型
收费全文 | 11616篇 |
免费 | 886篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 268篇 |
儿科学 | 585篇 |
妇产科学 | 371篇 |
基础医学 | 1061篇 |
口腔科学 | 708篇 |
临床医学 | 1071篇 |
内科学 | 2349篇 |
皮肤病学 | 294篇 |
神经病学 | 710篇 |
特种医学 | 574篇 |
外科学 | 2259篇 |
综合类 | 170篇 |
一般理论 | 5篇 |
预防医学 | 596篇 |
眼科学 | 364篇 |
药学 | 655篇 |
中国医学 | 24篇 |
肿瘤学 | 476篇 |
出版年
2023年 | 180篇 |
2022年 | 167篇 |
2021年 | 398篇 |
2020年 | 265篇 |
2019年 | 328篇 |
2018年 | 550篇 |
2017年 | 432篇 |
2016年 | 549篇 |
2015年 | 573篇 |
2014年 | 606篇 |
2013年 | 1084篇 |
2012年 | 685篇 |
2011年 | 714篇 |
2010年 | 612篇 |
2009年 | 401篇 |
2008年 | 429篇 |
2007年 | 377篇 |
2006年 | 500篇 |
2005年 | 456篇 |
2004年 | 322篇 |
2003年 | 306篇 |
2002年 | 268篇 |
2001年 | 200篇 |
2000年 | 182篇 |
1999年 | 201篇 |
1998年 | 169篇 |
1997年 | 132篇 |
1996年 | 153篇 |
1995年 | 99篇 |
1994年 | 105篇 |
1993年 | 99篇 |
1992年 | 82篇 |
1991年 | 81篇 |
1990年 | 67篇 |
1989年 | 44篇 |
1988年 | 57篇 |
1987年 | 35篇 |
1986年 | 53篇 |
1985年 | 37篇 |
1984年 | 45篇 |
1983年 | 38篇 |
1982年 | 32篇 |
1981年 | 34篇 |
1980年 | 31篇 |
1979年 | 30篇 |
1978年 | 25篇 |
1976年 | 18篇 |
1975年 | 19篇 |
1974年 | 28篇 |
1973年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Gaupp Spielmeyer Fischer Christeller Eisner-Behrend Hayward Peiper Becker Meesmann Kleinschmidt Oppenheimer Griesbach Herzfeld Deusch Schrader Magnus-Alsleben Nonnenbruch Edens Schübel Frik Tobler Emil Neisser Eckstein Weigert v. Jaschke Flaskamp Dietrich Langer Finkenrath Buschke KÖllner Mendel Steindorff Esch Preuss A. Gottstein 《Journal of molecular medicine (Berlin, Germany)》1924,3(15):642-648
Ohne Zusammenfassung 相似文献
102.
103.
Reinfurth Abderhalden E. Mangold Embden Emil Neisser Freudenberg Schübel Griesbach Tobler Hellwig Oppenheimer Melchior A. W. Fischer Hayward Manteufel Eisner Schiff Eisner-Behrend Weigert Deusch Simon Eckstein Edens Meyer Valentin Steiner Herzfeld Friedemann Lochte Goldstein Wiener Naef KÖllner Meesmann Steindorff Nadoleczny Preuss Esch SchÖnberg Vogel Euler Hauberrisser 《Journal of molecular medicine (Berlin, Germany)》1923,2(37-38):1767-1777
104.
105.
106.
Franz Buchegger Valentina Garibotto Thomas Zilli Laurent Allainmat Sandra Jorcano Hansjörg Vees Olivier Rager Charles Steiner Habib Zaidi Yann Seimbille Osman Ratib Raymond Miralbell 《European journal of nuclear medicine and molecular imaging》2014,41(1):68-78
Purpose
18F-Fluorocholine (FCH) and 11C-acetate (ACE) PET are widely used for detection of recurrent prostate cancer (PC). We present the first results of a comparative, prospective PET/CT study of both tracers evaluated in the same patients presenting with recurrence and low PSA to compare the diagnostic information provided by the two tracers.Methods
The study group comprised 23 patients studied for a rising PSA level after radical prostatectomy (RP, 7 patients, PSA ≤3 ng/ml), curative radiotherapy (RT, 7 patients, PSA ≤5 ng/ml) or RP and salvage RT (9 patients, PSA ≤5 ng/ml). Both FCH and ACE PET/CT scans were performed in a random sequence a median of 4 days (range 0 to 11 days) apart. FCH PET/CT was started at injection (307?±?16 MBq) with a 10-min dynamic acquisition of the prostate bed, followed by a whole-body PET scan and late (45 min) imaging of the pelvis. ACE PET/CT was performed as a double whole-body PET scan starting 5 and 22 min after injection (994?±?72 MBq), and a late view (45 min) of the prostate bed. PET/CT scans were blindly reviewed by two independent pairs of two experienced nuclear medicine physicians, discordant subgroup results being discussed to reach a consensus for positive, negative end equivocal results.Results
PET results were concordant in 88 out of 92 local, regional and distant findings (Cohen’s kappa 0.929). In particular, results were concordant in all patients concerning local status, bone metastases and distant findings. Lymph-node results were concordant in 19 patients and different in 4 patients. On a per-patient basis results were concordant in 22 of 23 patients (14 positive, 5 negative and 3 equivocal). In only one patient was ACE PET/CT positive for nodal metastases while FCH PET/CT was overall negative; interestingly, the ACE-positive and FCH-negative lymph nodes became positive in a second FCH PET/CT scan performed a few months later.Conclusion
Overall, ACE and FCH PET/CT showed excellent concordance, on both a per-lesion and a per-patient basis, suggesting that both tracers perform equally for recurrent prostate cancer staging. 相似文献107.
Thyroid carcinoma and benign thyroid diseases associated with primary hyperparathyroidism (PHPT) may cause difficulties in the diagnosis, localization and therapy of PHPT. In this study, we analysed coexistent thyroid pathologies in 51 patients who underwent neck exploration with a diagnosis of PHPT between 1999-2002. Five hundred thirteen patients who underwent thyroidectomy for nodular thyroid disease without a parathyroid pathology in histopathological examination served as controls. In patients with PHPT there were 43 cases (84.3%) of coexistent thyroid pathology. Nine patients (17.6 %) had coexistent papillary thyroid cancer. Nine patients (17.6 %) had lymphocytic thyroiditis, two (3.9%) had benign thyroid adenoma and 24 (47%) had nodular hyperplasia. In one patient (2%), there was intrathyroidal metastasis from a parathyroid cancer. One patient had coexistent lymphocytic thyroiditis and multifocal papillary cancer. One of the two cases with thyroid adenomas was Hürthle cell type. In the control group only 28 patients (5.5%) had thyroid malignancy (27 papillary cancer and one follicular cancer). In conclusion, the coexistent thyroid pathologies are highly prevalent in patients with PHPT and pre-and intra-operative thyroid examination should be performed to avoid overlooking important thyroid pathologies. 相似文献
108.
Salmaslioğlu A Erbil Y Dural C Işsever H Kapran Y Ozarmağan S Tezelman S 《World journal of surgery》2008,32(9):1948-1954
BACKGROUND: The primary goal of ultrasonography (US) in the evaluation of a thyroid nodule is to determine its malignancy, although the diagnosis of a malignant nodule on the basis of US alone is nearly impossible. The aim of this prospective study was to evaluate the predictive value of sonographic features in the preoperative diagnosis of malignant thyroid nodules, and to determine the important features of sonography. METHODS: This prospective study included 550 consecutive patients with , thyroid nodules. Nodules were divided into two groups on the basis of pathological diagnosis: group 1 consisted of 1,633 nodules with a benign pathology, and group 2 consisted of 293 nodules with a malignant pathology. RESULTS: Microcalcifications, blurred nodular margins, and solid and hypoechoic appearance were more common in malignant nodules compared to benign nodules (89.1% versus 5%; 64.5% versus 4.7%; 81.6% versus 30.6% ; and 62.5% versus 43.1%, respectively; p < 0.001). There was a positive correlation between the detection of malignant thyroid nodules and microcalcification (rs = 0.791, p = 0.0001), blurred nodular margin (rs = 0.625, p = 0.0001), solid appearance (rs = 0.376, p = 0.0001), and hypoechoic appearance (rs = 0.141, p = 0.0001). Microcalcifications, blurred nodular margins, and solid and hypoechoic appearance were independent determinants of malignancy upon US examination of thyroid nodules (OR: 159, OR: 37, OR: 9.9, and OR: 2.2, respectively). CONCLUSION: Although we did not identify a single feature indicative of malignancy in the sonographic examination of nodules, microcalcification and blurred margin were the strongest correlates for malignancy. 相似文献
109.
There are various changes in the thyroid gland and its function in chronic renal failure (CRF). These changes include lower levels of circulating thyroid hormone, altered peripheral hormone metabolism, decreased binding to carrier proteins, possible reduction in tissue hormone content, and increased iodine storage in the thyroid gland. The decrease of excretion of urinary iodine in CRF increases serum inorganic iodine level and iodine content of the thyroid, which consequently enlarges the gland. This study is designed to investigate the prevalence of goiter and thyroid dysfunction in patients with end-stage renal disease (ESRD) on hemodialysis (HD) in an iodine-deficient community. Eighty-seven (40 females and 47 males) HD patients and 169 (79 females and 90 males) healthy individuals as controls are included. Sex ratios for the patient and control groups are 0.85 and 0.88, respectively. Mean ages for the patient and control groups are 42.94 +/- 11.88 and 40.20 +/- 10.72 years, respectively. Examination of the thyroid gland using ultrasonography along with simultaneous measurement of blood levels of free-T4 (FT4), free-T3 (FT3), and thyrotropin (TSH) are made for every individual. The presence of goiter demonstrable by ultrasonography is found in 32.2% of the uremic patients and in 23.5% of the controls and its prevalence increases with age (P = 0.01). In 32 (36.8%) of the patients and 29 (17.1%) of the controls at least one thyroid nodule is found in ultrasonography. Between patients with or without a nodular goiter the authors could not observe any difference for duration of dialysis and serum levels of TSH, FT4, FT3, calcium, and albumin. In ESRD patients the prevalence of nodular goiter is higher for females (47.5% vs. 27.7%, P = 0.045) and increases with age (P = 0.04). Though incidence of hyperthyroidism is found to be similar for the two groups (1.14% in ESRD patients vs. 1.10% in controls), hypothyroidism is observed in 3.4% of ESRD patients but only 0.6% of controls. This high incidence of hypothyroidism and nodular goiter in ESRD patients shows that screening for thyroid dysfunction and goiter, using appropriate laboratory tests and ultrasonography, should be considered in evaluation of every ESRD patient. 相似文献
110.
Gizem Tezel Selin Seda Timur Filiz Kuralay R. Neslihan Gürsoy Kezban Ulubayram Levent Öner 《Journal of drug targeting》2021,29(1):29-45
Abstract Synthetic micro/nanomotors (MNMs) are novel, self-propelled nano or microscale devices that are widely used in drug transport, cell stimulation and isolation, bio-imaging, diagnostic and monitoring, sensing, photocatalysis and environmental remediation. Various preparation methods and propulsion mechanisms make MNMs “tailormade” nanosystems for the intended purpose or use. As the one of the newest members of nano carriers, MNMs open a new perspective especially for rapid drug transport and gene delivery. Although there exists limited number of in-vivo studies for drug delivery purposes, existence of in-vitro supportive data strongly encourages researchers to move on in this field and benefit from the manoeuvre capability of these novel systems. In this article, we reviewed the preparation and propulsion mechanisms of nanomotors in various fields with special attention to drug delivery systems. 相似文献